Berkshire Hathaway sold its $1.6 billion stake in UnitedHealth as shares surged from $271 to $394 per share.
Berkshire Hathaway fully exited its UnitedHealth Group position in Q1 2026, selling 5 million shares at approximately $394 each. The stake, initially valued at $1.6 billion, was acquired near a 15-year low of $271 per share during the stock’s 50% collapse in early 2025.
The rebound followed a series of setbacks, including the assassination of former CEO Brian Thompson, an earnings miss, and a DOJ criminal investigation into Medicare fraud allegations. UnitedHealth shares recovered 45% over nine months before Berkshire’s exit.
The trade reflects Berkshire’s contrarian strategy under Greg Abel, capitalizing on short-term volatility rather than long-term holdings.